73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Lower cancer screening rates differ by region, tied to social vulnerability

Lower cancer screening rates differ by region, tied to social vulnerability

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainPopulations in U.S. counties defined as more vulnerable based on social factors including socioeconomic sta

Lower cancer screening rates differ by region, tied to social vulnerability

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainPopulations in U.S. counties defined as more vulnerable based on social factors including socioeconomic sta
Endoscopic approaches feasible in surgery for sinonasal cancer

Endoscopic approaches feasible in surgery for sinonasal cancer

(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 inHead & Neck.Ahmed S. Abdelmeguid, M.D., Ph.D.,

Endoscopic approaches feasible in surgery for sinonasal cancer

(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 inHead & Neck.Ahmed S. Abdelmeguid, M.D., Ph.D.,
Researchers uncover dangers of celebrating 'victory' over cancer

Researchers uncover dangers of celebrating 'victory' over cancer

by Eric Lindberg,University of Southern CaliforniaResearchers find that bell-ringing rituals might reinforce negative memories of cancer treatment. Credit: Photo/F. Carter SmithIt's a staple

Researchers uncover dangers of celebrating 'victory' over cancer

by Eric Lindberg,University of Southern CaliforniaResearchers find that bell-ringing rituals might reinforce negative memories of cancer treatment. Credit: Photo/F. Carter SmithIt's a staple
NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar
Saccharin derivatives give cancer cells a not-so-sweet surprise

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can
Innovative test that detects complex DNA patterns may improve mesothelioma detection rate in blood

Innovative test that detects complex DNA patterns may improve mesothelioma detection rate in blood

by Susan Murphy,Mayo ClinicStudy design. Our study involved detecting junctions that result from chromosomal rearrangements, insertions and deletions in mesothelioma in Step 1, then designing pr

Innovative test that detects complex DNA patterns may improve mesothelioma detection rate in blood

by Susan Murphy,Mayo ClinicStudy design. Our study involved detecting junctions that result from chromosomal rearrangements, insertions and deletions in mesothelioma in Step 1, then designing pr
Chemotherapy before surgery cuts risk of colon cancer returning, trial finds

Chemotherapy before surgery cuts risk of colon cancer returning, trial finds

byCancer Research UKCredit: CC0 Public DomainGiving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to the results of a Cancer Research UK

Chemotherapy before surgery cuts risk of colon cancer returning, trial finds

byCancer Research UKCredit: CC0 Public DomainGiving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to the results of a Cancer Research UK
Germany's BioNTech plans UK trial of mRNA cancer therapy

Germany's BioNTech plans UK trial of mRNA cancer therapy

Scientists believe mRNA vaccines could be a game-changer against many diseases.German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in

Germany's BioNTech plans UK trial of mRNA cancer therapy

Scientists believe mRNA vaccines could be a game-changer against many diseases.German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in
Precision oncology approach shows potential for high grade gliomas harboring a genetic mutation

Precision oncology approach shows potential for high grade gliomas harboring a genetic mutation

by Nicole Fawcett,University of MichiganImmunostaining in a genetically engineered pediatric high grade glioma model harboring the H3-G34R mutation. Tumor cells are shown in green, nuclei in blu

Precision oncology approach shows potential for high grade gliomas harboring a genetic mutation

by Nicole Fawcett,University of MichiganImmunostaining in a genetically engineered pediatric high grade glioma model harboring the H3-G34R mutation. Tumor cells are shown in green, nuclei in blu
Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati
New therapeutic strategy for treating a very aggressive form of breast cancer

New therapeutic strategy for treating a very aggressive form of breast cancer

byCORDISCredit: CC0 Public DomainScientists have identified a new therapeutic strategy for treating a very aggressive form of breast cancer.Triple-negative breast cancer (TNBC) is one of the mos

New therapeutic strategy for treating a very aggressive form of breast cancer

byCORDISCredit: CC0 Public DomainScientists have identified a new therapeutic strategy for treating a very aggressive form of breast cancer.Triple-negative breast cancer (TNBC) is one of the mos
Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th